These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 33588861)

  • 1. Multifunctional lipid-based nanocarriers with antibacterial and anti-inflammatory activities for treating MRSA bacteremia in mice.
    Liao CC; Yu HP; Yang SC; Alalaiwe A; Dai YS; Liu FC; Fang JY
    J Nanobiotechnology; 2021 Feb; 19(1):48. PubMed ID: 33588861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-targeted combinatorial nanosystems for suppressing bacteremia-associated hyperinflammation and MRSA infection to improve survival rates.
    Chang YT; Lin CY; Chen CJ; Hwang E; Alshetaili A; Yu HP; Fang JY
    Acta Biomater; 2024 Jan; 174():331-344. PubMed ID: 38061677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian Staphylococcus aureus Sepsis Outcome Programme annual report, 2013.
    Coombs GW; Nimmo GR; Daly DA; Le TT; Pearson JC; Tan HL; Robinson JO; Collignon PJ; McLaws ML; Turnidge JD;
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E309-19. PubMed ID: 25631593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel chitosan-based pH-responsive lipid-polymer hybrid nanovesicles (OLA-LPHVs) for delivery of vancomycin against methicillin-resistant Staphylococcus aureus infections.
    Hassan D; Omolo CA; Fasiku VO; Mocktar C; Govender T
    Int J Biol Macromol; 2020 Mar; 147():385-398. PubMed ID: 31926237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet membrane-camouflaged silver metal-organic framework drug system against infections caused by methicillin-resistant Staphylococcus aureus.
    Huang R; Cai GQ; Li J; Li XS; Liu HT; Shang XL; Zhou JD; Nie XM; Gui R
    J Nanobiotechnology; 2021 Aug; 19(1):229. PubMed ID: 34348721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of free vancomycin and transcription factor decoy-nanostructured lipid carriers can enhance inhibition of methicillin resistant Staphylococcus aureus (MRSA).
    Hibbitts A; Lucía A; Serrano-Sevilla I; De Matteis L; McArthur M; de la Fuente JM; Aínsa JA; Navarro F
    PLoS One; 2019; 14(9):e0220684. PubMed ID: 31479462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms.
    Guo P; Buttaro BA; Xue HY; Tran NT; Wong HL
    Eur J Pharm Biopharm; 2020 Jun; 151():189-198. PubMed ID: 32335285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018.
    Coombs GW; Daley DA; Mowlaboccus S; Lee YT; Pang S;
    Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mohamed NM; Zakaria AS; Edward EA; Abdel-Bary A
    Pol J Microbiol; 2019; 68(1):59-69. PubMed ID: 31050254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloramphenicol encapsulated in poly-ε-caprolactone-pluronic composite: nanoparticles for treatment of MRSA-infected burn wounds.
    Kalita S; Devi B; Kandimalla R; Sharma KK; Sharma A; Kalita K; Kataki AC; Kotoky J
    Int J Nanomedicine; 2015; 10():2971-84. PubMed ID: 25931822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of methicillin-resistant Staphylococcus aureus infection by nanoliposomes loaded with gentamicin and oleic acid.
    Atashbeyk DG; Khameneh B; Tafaghodi M; Fazly Bazzaz BS
    Pharm Biol; 2014 Nov; 52(11):1423-8. PubMed ID: 25026343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University Adult and Oncology Hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study].
    Atmaca O; Zarakolu P; Karahan C; Cakır B; Unal S
    Mikrobiyol Bul; 2014 Oct; 48(4):523-37. PubMed ID: 25492648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate in combination with oxacillin protect sepsis model mice challenged with lethal live methicillin-resistant Staphylococcus aureus (MRSA) via its inhibition on proinflammatory cytokines release and enhancement on antibacterial activity of oxacillin.
    Jiang W; Li B; Zheng X; Liu X; Cen Y; Li J; Pan X; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2011 Aug; 11(8):1065-73. PubMed ID: 21396483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous absorption and antibacterial activities of lipid nanocarriers loaded with dual drugs for acne treatment.
    Lin CH; Fang YP; Al-Suwayeh SA; Yang SY; Fang JY
    Biol Pharm Bull; 2013; 36(2):276-86. PubMed ID: 23370356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
    Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
    Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
    Takesue Y; Nakajima K; Takahashi Y; Ichiki K; Ishihara M; Wada Y; Tsuchida T; Uchino M; Ikeuchi H
    J Infect Chemother; 2011 Feb; 17(1):52-7. PubMed ID: 20625789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin.
    Placencia FX; Kong L; Weisman LE
    Pediatr Res; 2009 Apr; 65(4):420-4. PubMed ID: 19127212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
    Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
    Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.